An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 9307733)

Published in Oral Oncol on May 01, 1997

Authors

M Carrozzo1, M Carbone, S Gandolfo, G Valente, P Colombatto, V Ghisetti

Author Affiliations

1: Department of Oral Medicine and Periodontology, School of Medicine and Dentistry, University of Turin, Italy.

Articles by these authors

Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat (2007) 2.87

Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol (2004) 2.46

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene (2000) 2.27

Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet (2001) 1.94

Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A (2000) 1.91

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer (1999) 1.86

The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J (1996) 1.75

The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med (1997) 1.69

The management of oral lichen planus. Oral Dis (1999) 1.68

SV40 induces mesotheliomas in hamsters. Am J Pathol (1993) 1.64

Oral acanthosis nigricans, tripe palms and sign of leser-trélat in a patient with gastric adenocarcinoma. Int J Dermatol (2004) 1.62

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. Hepatology (1998) 1.53

Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol (2006) 1.50

Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. Endocrine (2012) 1.50

Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients. Aliment Pharmacol Ther (2009) 1.49

Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer (1993) 1.48

Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation. Transpl Infect Dis (2007) 1.48

IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus-related disease? Eur J Gastroenterol Hepatol (1997) 1.47

Course of oral lichen planus: a retrospective study of 808 northern Italian patients. Oral Dis (2009) 1.44

Clinical features of microinvasive stage I oral carcinoma. Oral Dis (2010) 1.40

A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res (1998) 1.30

Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf) (2011) 1.25

Detection of Arcobacter spp. in the coastal environment of the Mediterranean Sea. Appl Environ Microbiol (2004) 1.17

Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci U S A (1999) 1.15

Oral mucosal dysplastic lesions and early squamous cell carcinomas: underdiagnosis from incisional biopsy. Oral Dis (2003) 1.10

Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1. J Cell Physiol (1997) 1.08

Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect Immun (1996) 1.06

The impact of liquid-based oral cytology on the diagnosis of oral squamous dysplasia and carcinoma. Cytopathology (2007) 1.06

Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med (1998) 1.04

Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax (2009) 1.03

Periodontal status in oral mucous membrane pemphigoid: initial results of a case-control study. Oral Dis (2011) 1.03

In vitro susceptibility of Arcobacter butzleri and Arcobacter cryaerophilus to different antimicrobial agents. Int J Antimicrob Agents (2003) 1.02

Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur J Immunol (2000) 1.01

The prevalence of oral mucosal lesions in adults from the Turin area. Oral Dis (2008) 1.01

Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem (1996) 1.00

Isolation of Arcobacter spp. from a brackish environment. New Microbiol (2000) 1.00

Simian virus 40 small-t antigen stimulates viral DNA replication in permissive monkey cells. J Virol (1994) 0.99

Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. Int J Cancer (1999) 0.99

Distribution of potentially pathogenic bacteria as free living and plankton associated in a marine coastal zone. J Appl Microbiol (2004) 0.99

Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor. Cancer Res (1996) 0.99

Sonographic appearance of aggressive angiomyxoma of the bladder. J Clin Ultrasound (1999) 0.99

SV40 and the pathogenesis of mesothelioma. Semin Cancer Biol (2001) 0.98

Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol (1999) 0.97

Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol (1997) 0.97

The hepatitis C virus carrier with "persistently" normal serum transaminases: a misleading clinical issue. Dig Liver Dis (2000) 0.97

Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest (1999) 0.96

Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma? J Clin Pathol (1994) 0.96

[Pediatric clinical experimentation with rifampicin. Therapeutic effect and tolerance]. Clin Pediatr (Bologna) (1969) 0.96

Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev (2012) 0.96

Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors. Clin Nephrol (1992) 0.95

Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol (1996) 0.94

Bone augmentation of the inferior floor of the maxillary sinus with autogenous bone or composite bone grafts: a histologic-histomorphometric preliminary report. Int J Oral Maxillofac Implants (1998) 0.94

Expansion and molecular evolution of the interferon-induced 2'-5' oligoadenylate synthetase gene family. Mol Biol Evol (2000) 0.94

Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med (1996) 0.93

Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcinog (1999) 0.93

Onconase mediated NFKβ downregulation in malignant pleural mesothelioma. Oncogene (2011) 0.93

SV40 small t deletion mutants preferentially transform mononuclear phagocytes and B lymphocytes in vivo. Virology (1992) 0.93

Small bowel metastasis from squamous cell carcinoma of the larynx. A case report. Tumori (1993) 0.93

Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice. J Infect Dis (1997) 0.92

Localized oral amyloidosis of the palate. Amyloid (2006) 0.92

Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray-zone" for the evaluation of "borderline" values. J Hepatol (1996) 0.92

Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol (2001) 0.91

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer (2000) 0.91

Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease? J Clin Pathol (1993) 0.90

Angiogenesis: prognostic significance in laryngeal cancer. Anticancer Res (1999) 0.90

Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis. Nephron (1999) 0.90

Study of ethmoidal mucosa in a population at occupational high risk of sinonasal adenocarcinoma. Acta Otolaryngol (2002) 0.90

Delayed acquisition of high-avidity anti-cytomegalovirus antibody is correlated with prolonged antigenemia in solid organ transplant recipients. J Infect Dis (1998) 0.89

Benign papillary mesothelioma of the tunica vaginalis testis. Arch Pathol Lab Med (2000) 0.89

[Erythema multiforme. A heterogeneous pathologic phenotype]. Minerva Stomatol (1999) 0.89

Cancer risk associated with simian virus 40 contaminated polio vaccine. Anticancer Res (1999) 0.89

Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha. J Hepatol (1995) 0.89

Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes. Infect Immun (1997) 0.88

Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med (2003) 0.88

Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon. Ital J Gastroenterol Hepatol (1997) 0.88

Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy. J Antimicrob Chemother (2013) 0.88

Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. J Antimicrob Chemother (2007) 0.88

MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J Clin Pathol (1994) 0.87

Hepatitis C virus-associated oral lichen planus: no influence from hepatitis G virus co-infection. J Oral Pathol Med (2000) 0.87

Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med (1994) 0.86

Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions. Cell Oncol (Dordr) (2011) 0.86

Verrucous oral carcinoma: clinical findings and treatment outcomes in 74 patients in Northwest Italy. Minerva Stomatol (2008) 0.86

Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 0.86

Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology (2004) 0.85

Oral lichen planus in patients infected or noninfected with hepatitis C virus: the role of autoimmunity. J Oral Pathol Med (1999) 0.85

Galactosylceramidase deficiency causes sperm abnormalities in the mouse model of globoid cell leukodystrophy. Exp Cell Res (2004) 0.85

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes. J Viral Hepat (2013) 0.85

Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. Oral Oncol (1998) 0.85

Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10. Clin Diagn Lab Immunol (1997) 0.85

Is transposed skin transformed in major head and neck mucosal reconstruction? Acta Otolaryngol (1995) 0.85